LBF16306HO01: Difference between revisions
No edit summary |
No edit summary |
||
| Line 8: | Line 8: | ||
|SysName=8R-hydroxy-4Z,6E,10Z-hexadecatrienoic acid | |SysName=8R-hydroxy-4Z,6E,10Z-hexadecatrienoic acid | ||
|Common Name=&&8R-hydroxy-4Z,6E,10Z-hexadecatrienoic acid&& | |Common Name=&&8R-hydroxy-4Z,6E,10Z-hexadecatrienoic acid&& | ||
|UV Spectra= | |UV Spectra= lambda max: 234nm epsilon : 23,000 | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism=Metabolism of 12(R)-HETE in corneal tissue produces predominantly the compound resulting from the loss of four carbon atoms through beta-oxidation from C-1 [[Reference:Nishimura_M:Schwartzman_ML:Falck_JR:Lumin_S:Zirrolli_JA:Murphy_RC:,Arch. Biochem. Biophys.,1991,290,326|{{RelationTable/GetFirstAuthor|Reference:Nishimura_M:Schwartzman_ML:Falck_JR:Lumin_S:Zirrolli_JA:Murphy_RC:,Arch. Biochem. Biophys.,1991,290,326}}]]. This metabolite is 8(R)-hydroxy hexadecatrienoic acid (8(R)-HHxTrE) or 2,3,4,5-tetranor 12(R)-HETE. | |Metabolism=Metabolism of 12(R)-HETE in corneal tissue produces predominantly the compound resulting from the loss of four carbon atoms through beta -oxidation from C-1 [[Reference:Nishimura_M:Schwartzman_ML:Falck_JR:Lumin_S:Zirrolli_JA:Murphy_RC:,Arch. Biochem. Biophys.,1991,290,326|{{RelationTable/GetFirstAuthor|Reference:Nishimura_M:Schwartzman_ML:Falck_JR:Lumin_S:Zirrolli_JA:Murphy_RC:,Arch. Biochem. Biophys.,1991,290,326}}]]. This metabolite is 8(R)-hydroxy hexadecatrienoic acid (8(R)-HHxTrE) or 2,3,4,5-tetranor 12(R)-HETE. | ||
|Symbol=8(R)-HHxTrE/2,3,4,5-tetranor 12(R)-HETE | |Symbol=8(R)-HHxTrE/2,3,4,5-tetranor 12(R)-HETE | ||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 23:00, 19 February 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | DFA8137 |
| LipidMaps | LMFA01050143 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF16306HO01 |
| 8R-hydroxy-4Z,6E,10Z-hexadecatrienoic acid | |
|---|---|
| |
| Structural Information | |
| 8R-hydroxy-4Z,6E,10Z-hexadecatrienoic acid | |
| |
| 8(R)-HHxTrE/2,3,4,5-tetranor 12(R)-HETE | |
| Formula | C16H26O3 |
| Exact Mass | 266.18819469799996 |
| Average Mass | 266.37584 |
| SMILES | CCCCCC=CCC(O)C=CC=CCCC(O)=O |
| Physicochemical Information | |
| Metabolism of 12(R)-HETE in corneal tissue produces predominantly the compound resulting from the loss of four carbon atoms through beta -oxidation from C-1 Nishimura_M et al.. This metabolite is 8(R)-hydroxy hexadecatrienoic acid (8(R)-HHxTrE) or 2,3,4,5-tetranor 12(R)-HETE. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | λ max: 234nm ε : 23,000 |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| [hide]Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
